Literature DB >> 11561107

Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate.

P J Richards1, B D Williams, A S Williams.   

Abstract

OBJECTIVES: To investigate the role of macrophages in the pathogenesis of chronic streptococcal cell wall (SCW)-induced arthritis using liposomal clodronate.
METHODS: Female Lewis rats with SCW-induced arthritis received a single intravenous injection of 20 mg of clodronate encapsulated within small unilamellar vesicles (SUVc) 10 days post-arthritis induction.
RESULTS: SUVc significantly suppressed the development of chronic SCW-induced arthritis for up to 26 days after treatment. At this time point, ED1(+) macrophages were significantly depleted in the liver and ankle joints, although splenic macrophage numbers were not significantly different from control groups. Macrophage elimination induced a significant reduction in local levels of interleukin (IL)-1beta, IL-6, tumour necrosis factor-alpha (TNFalpha) and matrix metalloproteinase-9 (MMP-9) from ankle joints.
CONCLUSIONS: Macrophage elimination by SUVc inhibits local production of IL-1beta, IL-6, TNFalpha and MMP-9, and the pathogenesis of inflammatory arthritis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561107     DOI: 10.1093/rheumatology/40.9.978

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  10 in total

Review 1.  Development of macromolecular prodrug for rheumatoid arthritis.

Authors:  Fang Yuan; Ling-dong Quan; Liao Cui; Steven R Goldring; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

Review 2.  Innate immunity and rheumatoid arthritis.

Authors:  Angelica Gierut; Harris Perlman; Richard M Pope
Journal:  Rheum Dis Clin North Am       Date:  2010-05       Impact factor: 2.670

Review 3.  Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.

Authors:  Wiebke Ulbrich; Alf Lamprecht
Journal:  J R Soc Interface       Date:  2009-11-25       Impact factor: 4.118

4.  Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis.

Authors:  J M Metselaar; W B van den Berg; A E M Holthuysen; M H M Wauben; G Storm; P L E M van Lent
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

5.  Targeted liposomal drug delivery to monocytes and macrophages.

Authors:  Ciara Kelly; Caroline Jefferies; Sally-Ann Cryan
Journal:  J Drug Deliv       Date:  2010-10-26

Review 6.  Application of liposomes in treatment of rheumatoid arthritis: quo vadis.

Authors:  Bhupinder Kapoor; Sachin Kumar Singh; Monica Gulati; Reena Gupta; Yogyata Vaidya
Journal:  ScientificWorldJournal       Date:  2014-02-04

Review 7.  Applications of nanotechnology for immunology.

Authors:  Douglas M Smith; Jakub K Simon; James R Baker
Journal:  Nat Rev Immunol       Date:  2013-08       Impact factor: 53.106

8.  Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: a potential cell-based therapy?

Authors:  Sylvain Perruche; Philippe Saas; Wanjun Chen
Journal:  Arthritis Res Ther       Date:  2009-07-02       Impact factor: 5.156

9.  Anti-arthritis activity of cationic materials.

Authors:  Lei Dong; Suhua Xia; Huan Chen; Jiangning Chen; Junfeng Zhang
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

Review 10.  Liposomal Nanosystems in Rheumatoid Arthritis.

Authors:  Margarida Ferreira-Silva; Catarina Faria-Silva; Pedro Viana Baptista; Eduarda Fernandes; Alexandra Ramos Fernandes; Maria Luísa Corvo
Journal:  Pharmaceutics       Date:  2021-03-27       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.